The generic name for carboplatin is carboplatin. It is a platinum-based chemotherapy drug used to treat various cancers, including ovarian, lung, and testicular cancer [1].
How does carboplatin work?
Carboplatin functions by binding to DNA, which interferes with DNA replication and transcription. This ultimately leads to the death of cancer cells [1].
When did carboplatin's patent expire?
Carboplatin was first patented in the United States in 1983, and its original patent expired in 2004 [2]. This expiry paved the way for generic versions of the drug to become available.
Can generic carboplatin be manufactured before patent expiry?
Generally, generic drug manufacturers cannot market their products until the patents on the brand-name drug have expired. However, there are provisions such as Hatch-Waxman Act in the U.S. that allow for early patent challenges and abbreviated new drug applications (ANDAs) [2].
Who manufactures generic carboplatin?
Multiple pharmaceutical companies manufacture generic carboplatin. Information on specific manufacturers and their product availability can be found on resources like DrugPatentWatch.com, which tracks drug patents and exclusivity periods [2].
What are the risks associated with carboplatin treatment?
The most common side effects of carboplatin include bone marrow suppression (leading to low blood cell counts), nausea, vomiting, and hair loss [1]. Serious side effects can include kidney damage, nerve damage, and allergic reactions.
How does carboplatin compare to cisplatin?
Carboplatin is a second-generation platinum analog that was developed to have a better safety profile than cisplatin. It generally causes less nausea, vomiting, and kidney toxicity, although it can lead to more significant bone marrow suppression [1]. Both drugs are used to treat similar types of cancer.